Search

Glyn Denison

Glyn Denison operates his own business consultancy advising companies in their development internationally. Mr Denison was one of the founders of the ERG Group and held several senior executive positions over the period from 1987 to 2003. These positions included President of the Americas for the ERG fare collection business and the New Business Development Director for ERG Transit. Prior to ERG, Mr Denison held several commercial positions with Bunnings Forest Products (now part of the Wesfarmers Group). Mr Denison is an Executive Consultant to Evans & Peck Pty Ltd providing engineering advice to various construction and mining companies as well as business advisory to a number of major insurance, land development and accounting firms as they respond to the local fast growing economy.
Bio last updated 08 Dec 2018

Positions - Previous

PositionCompanyYearCompany's current rankWA staff
Non-Executive Chairman
OBJ
OBJ
2006 - 2018135
Co-Founder, Non-Executive Director
DTI Group
DTI Group
2004 - 201869

Directors Interests

CompanyDateTransaction typeNumber of sharesPrice per shareTransaction valueNature of change
OBJ02 Feb 2018Other16,242,105$0.00OtherOff-market transfer: Assuming 16,242,105 Indirect shares transferred to Direct shares.As per announcement on 05/02/2018.
OBJ02 Feb 2018Other16,242,105$0.00OtherOff-market transfer: Assuming 16,242,105 Indirect shares transferred to Direct shares.
OBJ31 Aug 2017Bought5,000,000$0.00OtherConversion of securities
OBJ31 Aug 2017Other5,000,000$0.00OtherConversion of securities: 10,000,000 - Performance Rights
DTI Group20 Dec 2016Issued142,857$0.35$50,000Rights issue

Directors Shareholdings

CompanyDirect sharesIndirect sharesTotal sharesTotal value
OBJ11,242,10511,242,105$191,116
DTI Group3,030,4953,030,495$139,403

Equity Capital Markets Deals

DateCompanyTransaction TypeTotal Value
02/11/15OBJPlacement and entitlement offer$6.7m>>
27/09/13OBJPlacement$1.9m>>

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
75thBotanix Pharmaceuticals50%93%
290thConnected IO0%-34%
663rdOBJ-53%-10%
729thSyntonic-62%-4%
823rdThred-81%-43%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Revenue

135th↓OBJ$2.0m
136th↑Thred$1.8m
137th↑Syntonic$1.8m
139th↑Botanix Pharmaceuticals$1.8m
140th↓Connected IO$1.7m
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer